Filing Flows › Spruce Biosciences (SPRB) › Q4 2024 › vs Q4 2023
Spruce Biosciences (SPRB) Q4 2024 vs Q4 2023 (year over year)
Spruce Biosciences's revenue fell $2.2M (-76%) from $2.9M in Q4 2023 to $697K in Q4 2024.
Spruce Biosciences, Q4 2024: revenue $697K (-76% year over year), net loss $23.6M, operating cash flow −$20.7M. The chart draws each line against Q4 2023, the increases inside each band.
Every line
| Line | Q4 2024 | Q4 2023 | Change | % |
|---|---|---|---|---|
| Revenue | $697K | $2.9M | −$2.2M | -76% |
| Other income, net | $515K | $1.2M | −$699K | -58% |
| Net loss | $23.6M | $9.9M | $13.6M | +137% |
| Costs & expenses | $24.8M | $14.1M | $10.7M | +76% |
| Operating costs | $24.8M | $14.1M | $10.7M | +76% |
| Research & development | $21.5M | $11.1M | $10.4M | +93% |
| General & admin | $3.3M | $3.0M | $363K | +12% |
| Operating cash sources | $23.6M | $9.9M | $13.6M | +137% |
| Depreciation & amortization | $9K | $16K | −$7K | -44% |
| Share-based compensation | $961K | $1.2M | −$260K | -21% |
| Working capital & other | $1.9M | −$2.5M | $4.4M | — |
| Cash used in operations | $20.7M | $11.2M | $9.5M | +84% |
| Net loss absorbed | $23.6M | $9.9M | $13.6M | +137% |
Questions
How much did Spruce Biosciences's revenue grow year over year in Q4 2024?
Spruce Biosciences's revenue fell $2.2M (-76%) from $2.9M in Q4 2023 to $697K in Q4 2024.